Prostate Cancer

Research activity is centered on castration-resistant prostate cancer, with a focus on disease control in men whose cancer no longer responds to androgen deprivation. The clinical interest extends to non-metastatic castration-resistant prostate cancer and the prevention of spread to distant sites.

• Metastasis-free survival
• Non-metastatic castration-resistant prostate cancer
• Androgen receptor inhibition

The sponsor’s work in this area reflects a therapeutic emphasis on delaying metastatic progression in advanced prostate cancer and supporting treatment options for men with high-risk disease.